Posted on May 31, 2010 - by admin
GSK tries an open-source strategy for drug development | PharmaFeed
Now GlaxoSmithKline is trying a whole new approach, creating a unique open – source development program that will offer up 13500 chemical compounds that have the potential to throttle the parasites that cause malaria. …
See the original post here:
GSK tries an open-source strategy for drug development | PharmaFeed
